Corona and Parley for the Oceans partner with Stephanie Gilmore, Gabriel Medina and artists to support the ban of single-use plastic in Bali and provide households with reusable alternatives.
It is estimated that roughly 5 trillion plastic bags are consumed worldwide each year1 with as many as 10 million plastic bags entering circulation in Indonesia every day2. Earlier this year, Bali announced a ban of all single-use plastic (including plastic bags) that takes affect later this year. For the first time, Balinese would have to rely on reusable bags exclusively.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190514005361/en/
Corona's La Casa pop-up space, made from 1.5 tons of recycled plastic. (Photo: Business Wire)
To help support the local NGOs who have been leading the charge against single-use plastic and as part of their commitment to the region where the annual Bali Pro-tected surf event takes place, Corona, Parley and World Surf League are donating 20,000 reusable bags made from Ocean Plastic®. Limited edition bags are also being created on-site and will be sold in real-time at wslstore.com. The proceeds from each bag purchased funds the donation of an additional 3 bags to the local community and the removal of more than 20 bottles worth of plastic. The ambition over time is to provide one bag for every household in Indonesia.
The limited-edition bags were designed by Stephanie Gilmore, Gabriel Medina and Rosy Hodge in partnership with artists Nadia Hernandez, Speto and Gemma O’Brien respectively. Surfers on the WSL Championship Tour have also shown their support by designing their own bags to raise awareness of the project. The collaborators are part of the inaugural “La Casa” pop-up, a house made from 1.5 tons of recycled plastic in partnership with NevHouse. Founded by Corona, the house will become a platform for surfers, artists and thought-leaders to work on projects that can inspire a better world. The house itself is a positive reminder that plastic can be given a meaningful second life, much like the bags. Each pop-up will include new collaborators and new projects to help protect paradise from plastic pollution.
“The La Casa platform is about collaboration and creativity to energize the fight against marine plastic pollution,” said Evan Ellman, Corona Better World Director. “In this case, Corona and our partners Parley and World Surf League, were inspired by the movement to ban single-use plastic in Bali and recognized an opportunity to support the transition. Just as impressive are the talented collaborators who signed on to bring their voice and point of view to the project. The result is a product that is not only a symbol of change, but also has a significant impact on the environment and community.”
La Casa is the latest initiative from Corona and Parley for the Oceans who have a mutual mission to protect the world’s oceans and beaches. To date, the partnership has engaged in 100 islands around the world through a clean-up network present in over 23 countries, resulting in 537 clean-ups, 25,000 volunteers and more than 3 million square meters of beach cleaned. This includes Corona’s support of Parley’s strategy to end marine plastic pollution: A.I.R. (Avoid, Intercept and Redesign). Most recently, Corona and Parley partnered with Oscar-nominated stop-motion artist PES to create a film on Earth Day raising awareness that “avoiding” and “intercepting” plastic saves the lives of marine wildlife. The La Casa initiative in Bali is an example of how that plastic can be “redesigned” into a product that replaces single-use plastic.
La Casa Corona will be at the Corona Bali Pro-tected event in Keramas, Bali, Indonesia from May 13 - May 25, 2019. To learn more and purchase a bag visit wslstore.com.
-###-
ABOUT CORONA
Born in Mexico, Corona is the leading beer brand in the country, the most popular Mexican beer worldwide exported to more than 180 countries. Corona Extra was first brewed in 1925 at the Cervecería Modelo in Mexico City. Corona is a pioneer in the beer industry by being the first to use a transparent bottle showcasing its purity and high quality to the world. The artwork found on the bottle is painted, highlighting our commitment to quality in our packaging and our Mexican heritage. No Corona is complete without the lime. Naturally adding character, flavor and refreshment, the lime ritual is an integral part of delivering an experience that is truly unique to Corona. The brand is synonymous with the beach and celebrates time outdoors. It invites people to pause, relax and enjoy the simple pleasures of life.
ABOUT PARLEY FOR THE OCEANS
Parley for the Oceans is the global network where creators, thinkers and leaders from the creative industries, brands, governments and environmental groups come together to raise awareness for the beauty and fragility of the oceans and collaborate on projects that can end their destruction. The organization has formed alliances with major corporations including adidas, Anheuser Busch InBev (Corona), American Express; the United Nations; the Maldives and collaborators spanning the worlds of science, art, fashion, design, entertainment, sports, and space and ocean exploration. To know more: www.parley.tv
ABOUT THE WSL
The World Surf League (WSL) is the global home of surfing, dedicated to celebrating the world's best surfing on the world's best waves. The WSL has been championing the world's best surfing since 1976, annually running more than 180 global events across the Men's and Women's Championship Tours, the Big Wave Tour, the Longboard Tour, Qualifying Series, Pro Junior Tour, as well as the WSL Big Wave Awards. The League possesses a deep appreciation for the sport's rich heritage while promoting progression, innovation, and performance at the highest levels, and in doing so crowns the undisputed Men’s and Women’s World Champions across all tours. For more information, please visit WorldSurfLeague.com.
1
https://wedocs.unep.org/bitstream/handle/20.500.11822/25513/state_plastics_WED.pdf?isAllowed=y&sequence=1
2
https://www.theinertia.com/environment/indonesia-pledges-1-billion-a-year-to-reduce-its-ocean-waste/
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190514005361/en/
Contact information
Alison Brod Marketing + Communications:
Corona@alisonbrodmc.com
212-230-1800
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 18:00:00 EET | Press release
AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th
CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 14:00:00 EET | Press release
Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships Powering the Summit CoMotion GLOBAL 2025 is hosted by the Saudi Conventions & Exhibitions General Authority (SCEGA), supported by key Saudi
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67 th American Society of Hematology (ASH) Annual Meeting6.12.2025 16:30:00 EET | Press release
Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which Ono obtained exclusive global rights for the development and commercialization of sapablursen. “In the treatment of PV, phlebotomy and cytoreductive therapy are performed as treatments for preventing thrombosis. Phlebotomy is the most common treatment for PV, in which blood
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 16:30:00 EET | Press release
Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society of Hematology (ASH) Annual Meeting and Exposition. These findings further reinforce rusfertide’s efficacy and safety and demonstrate durability of response, with 61.9% of patients continuously treated with rusfertide maintaining absence of phlebotomy eligibility from baseline to Week 52. “The 52-week data demonstrated the sustained efficacy of rusfertide, reducing the need for patients to receive phlebotomy while maintaining hematocrit control,” said Dr. Andrew T. Kuykendall, M.D., VERIFY Lead Investigator and Associate Member in the Department of Hematology at Moffitt Cancer Center. “The 32-week VERIFY primary results were already promising, and this deeper understanding of the durability of r
Vertex Presents New Data on CASGEVY ® , Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 14:01:00 EET | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and TDT ages 12 years and older, will be presented at the American Society of Hematology (ASH) Annual Meeting. CASGEVY is currently approved for eligible people ages 12 years and older with SCD or TDT in the United States, Great Britain, the European Union, the Kingdom of Saudi Arabia, the Kingdom of Bahrain, Kuwait, Qatar, Canada, Switzerland and the United Arab Emirates. “These results — the first clinical data ever presented on any genetic therapy for children ages 5-11 years with SCD — again demonstrate the tr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
